24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
REGOLIEVA 40MG is an Tablet medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | REGOLIEVA 40MG |
|---|---|
| Composition | Regorafenib Tablet BP 40mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Tablet |
| Packaging | Pack of 28 Tablets |
| Country of Origin | India |
Regorafenib Tablet BP 40mg (Regorafenib Tablet BP 40mg) is a widely used Tablet medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
Regolieva contains Regorafenib, an oral targeted anticancer medicine. It is a multi-kinase inhibitor that blocks enzymes involved in tumor cell growth, angiogenesis (formation of new blood vessels), and cancer progression, thereby slowing or stopping the spread of cancer.
Regolieva (Regorafenib) is used in adults for the treatment of:
Metastatic Colorectal Cancer (mCRC)
– After failure of standard chemotherapy and biological therapies
Gastrointestinal Stromal Tumor (GIST)
– In patients previously treated with imatinib and sunitinib
Hepatocellular Carcinoma (HCC)
– In patients who were previously treated with sorafenib
Common side effects:
Fatigue, weakness
Hand–foot skin reaction (palmar-plantar erythrodysesthesia)
Diarrhea
Decreased appetite, weight loss
Mouth sores (stomatitis)
Hair thinning or hair loss
High blood pressure
Recommended dose:
160 mg once daily (4 tablets of 40 mg)
Taken for 21 consecutive days, followed by 7 days off
One treatment cycle = 28 days
Take tablets after a low-fat meal
Swallow whole with water (do not crush or chew)